Sequence Analysis of the Chromosomal Region Around and Within the V-1-encoding Gene of Mycoplasma Pulmonis: Evidence for DNA Inversion As a Mechanism for V-1 Variation
Overview
Affiliations
Although the variation of V-1 antigens of Mycoplasma pulmonis has been correlated with variable expression of the cytadherence properties of this organism and has been implicated as a virulence determining factor in M. pulmonis-induced murine respiratory disease, the precise function of these antigens remains unknown. We have cloned and characterized genes encoding V-1 from two M. pulmonis UAB CT V-1 variants that differ in hemadsorption properties. A comparison of the nucleotide sequences revealed that these two variant genes were identical in the 5'-most 724 nucleotides. Regions of extensive divergence that contained repeated sequences were found 3' to this conserved region. On the basis of their deduced amino acid sequences, one variant expressed a V-1 protein of 94.2 kDa presumptively containing 40 repeats of 17 amino acids and the other expressed a protein of 27.4 kDa consisting 2 direct, noncontiguous 9-amino-acid repeats. These general properties, as well as the presence of a prokaryotic lipoprotein acylation sequence (L-X-Y-C), indicated that the genes encoding V-1 were similar in structure to genes encoding other mycoplasma surface lipoproteins. Further analysis of sequences flanking these genes revealed that these variants arose via an inversion event which provided an interchange of the two variable regions as well as for the conserved region of these genes and immunoblot analyses using rabbit polyclonal antibodies specific for synthetic peptides derived from the sequences of the different variable regions indicated that DNA inversion acted as a switch which allowed only one of the two different genes to be expressed at any given time. This inversion model clearly provides a mechanism by which M. pulmonis can alter its surface architecture and also strongly suggests that the as-yet-undefined function of V-1 residues in the variable carboxy region of these proteins.
Research Progress on Immune Evasion of .
Jiang B, Zhang Y, Li G, Quan Y, Shu J, Feng H Microorganisms. 2024; 12(7).
PMID: 39065207 PMC: 11279058. DOI: 10.3390/microorganisms12071439.
Unveiling the stealthy tactics: mycoplasma's immune evasion strategies.
Wang J, Liang K, Chen L, Su X, Liao D, Yu J Front Cell Infect Microbiol. 2023; 13:1247182.
PMID: 37719671 PMC: 10502178. DOI: 10.3389/fcimb.2023.1247182.
Mycoplasma polysaccharide protects against complement.
Bolland J, Simmons W, Daubenspeck J, Dybvig K Microbiology (Reading). 2012; 158(Pt 7):1867-1873.
PMID: 22504437 PMC: 3542145. DOI: 10.1099/mic.0.058222-0.
Bolland J, Dybvig K FEMS Microbiol Lett. 2012; 331(1):25-30.
PMID: 22428866 PMC: 3343211. DOI: 10.1111/j.1574-6968.2012.02551.x.
A stochastic mechanism for biofilm formation by Mycoplasma pulmonis.
Simmons W, Bolland J, Daubenspeck J, Dybvig K J Bacteriol. 2006; 189(5):1905-13.
PMID: 17142389 PMC: 1855698. DOI: 10.1128/JB.01512-06.